pzena investment management llc increased its holdings in shares of Mylan N.V. (NASDAQ:MYL) by 84.1% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 22,721,384 shares of the company’s stock after purchasing an additional 10,381,697 shares during the period. Mylan accounts for 3.8% of Pzena Investment Management LLC’s holdings, making the stock its biggest holding. Pzena Investment Management LLC owned about 4.24% of Mylan worth $712,770,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. principal financial group inc. raised its holdings in shares of Mylan by 11.4% in the third quarter. Principal Financial Group Inc. now owns 815,517 shares of the company’s stock worth $25,583,000 after buying an additional 83,481 shares during the last quarter. oregon public employees retirement fund raised its holdings in shares of Mylan by 1.8% in the third quarter. Oregon Public Employees Retirement Fund now owns 173,785 shares of the company’s stock worth $5,452,000 after buying an additional 3,041 shares during the last quarter. vantage financial partners ltd. Inc. raised its holdings in shares of Mylan by 49.5% in the third quarter. Vantage Financial Partners Ltd. Inc. now owns 41,400 shares of the company’s stock worth $1,391,000 after buying an additional 13,700 shares during the last quarter. State of wisconsin investment board raised its holdings in shares of Mylan by 11.5% in the third quarter. State of Wisconsin Investment Board now owns 1,243,810 shares of the company’s stock worth $39,018,000 after buying an additional 127,842 shares during the last quarter. Finally, Mivtachim The workers social insurance fund ltd. Under Special Management raised its holdings in shares of Mylan by 6.4% in the third quarter. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management now owns 2,311,700 shares of the company’s stock worth $72,518,000 after buying an additional 138,500 shares during the last quarter. Hedge funds and other institutional investors own 73.35% of the company’s stock.
MYL has been the subject of a number of research analyst reports. Cowen Inc reaffirmed a “market perform” rating and issued a $36.00 price target (up previously from $30.00) on shares of Mylan in a report on Thursday, October 5th. Mizuho reaffirmed a “buy” rating and issued a $37.00 price target on shares of Mylan in a report on Tuesday, October 24th. zacks investment research cut shares of Mylan from a “buy” rating to a “hold” rating in a report on Wednesday, November 8th. Citigroup Inc. set a $42.00 price target on shares of Mylan and gave the stock a “buy” rating in a report on Wednesday, October 4th. Finally, BidaskClub raised shares of Mylan from a “strong sell” rating to a “sell” rating in a report on Thursday, September 7th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and thirteen have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $41.49.
Mylan N.V. (MYL) traded up $0.09 during mid-day trading on Friday, reaching $37.37. 4,938,554 shares of the company traded hands, compared to its average volume of 5,212,191. The firm has a market capitalization of $19,998.34, a price-to-earnings ratio of 7.93, a PEG ratio of 2.04 and a beta of 1.38. The company has a current ratio of 1.46, a quick ratio of 0.95 and a debt-to-equity ratio of 1.05. Mylan N.V. has a 52 week low of $29.39 and a 52 week high of $45.87.
Mylan (NASDAQ:MYL) last released its quarterly earnings results on Monday, November 6th. The company reported $1.10 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.20 by ($0.10). Mylan had a net margin of 7.28% and a return on equity of 20.63%. The firm had revenue of $2.99 billion for the quarter, compared to analyst estimates of $3.09 billion. During the same quarter in the prior year, the business posted $1.38 EPS. The firm’s quarterly revenue was down 2.3% compared to the same quarter last year. research analysts predict that Mylan N.V. will post 4.56 EPS for the current year.
illegal activity notice: “Mylan N.V. (MYL) is Pzena Investment Management LLC’s Largest Position” was originally published by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this report on another website, it was illegally copied and republished in violation of United States & international copyright & trademark legislation. The correct version of this report can be accessed at https://stocknewstimes.com/2017/11/26/pzena-investment-management-llc-acquires-10381697-shares-of-mylan-n-v-myl.html.
Mylan Company Profile
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Receive News & Ratings for Mylan N.V. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Mylan N.V. and related companies with MarketBeat.com’s FREE daily email newsletter.